TuHURA Biosciences (HURA) 8-K Summary

TuHURA Biosciences entered into an At The Market (ATM) Offering Agreement on November 3, 2025, with H.C. Wainwright & Co., LLC.

• Offering Size: Up to $50,000,000 aggregate offering price of Common Stock.
• Mechanism: Sales proceed under a new Form S-3 shelf registration statement (pending SEC effectiveness).
• Costs: 3.0% cash commission plus legal expense reimbursement up to $75,000.
• Use of Proceeds: Intended for working capital and general corporate purposes.
• Important Note: The Company is not obligated